"Baptist Health Corbin, a 273-bed acute and skilled care hospital, provides a broad spectrum of healthcare services to residents of Whitley, Knox, Laurel, Bell, Clay, McCreary, Harlan and Campbell counties and Jellico, Tenn. Baptist Health Corbin is a vital part of its community, with outreach and education programs to address conditions such as diabetes, cancer and heart disease."

During the past decade, Baptist Health Corbin conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 22 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 19 clinical trials were completed. i.e. 316.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Health Corbin" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "NRG Oncology" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Health Corbin" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Health Corbin" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (5 trials), "Stage IIIA Breast Cancer AJCC v7" (4 trials) and "Stage IIIC Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Baptist Health Corbin" in a lesser frequency.

Most popular intervention types in "Baptist Health Corbin" are "Other" (44 trials), "Drug" (40 trials), "Biological" (22 trials), "Procedure" (14 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (13 trials), "Nivolumab" (9 trials), "Computed Tomography" (7 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health Corbin" are 39 trials for "All" genders and 14 trials for "Female" genders.

Currently, there are NaN active trials in "Baptist Health Corbin". undefined are not yet recruiting, 9 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Baptist Health Corbin, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health Corbin, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".